Cereus (USPharmaCo)


Welcome to the PulseAid listing for the Cereus drug offered from USPharmaCo. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: USPharmaCo
NON-PROPRIETARY NAME: Bacillus cereus
SUBSTANCE NAME: BACILLUS CEREUS
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2009-12-15
END MARKETING DATE: 0000-00-00


Cereus HUMAN OTC DRUG Details:

Item DescriptionCereus from USPharmaCo
LABELER NAME: USPharmaCo
DEA SCHEDULE:
ACTIVE STRENGTH: 6([hp_X]/5mL)
START MARKETING DATE: 2009-12-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 49693-2001_323bf388-43f1-42de-adc8-265ca164aa6f
PRODUCT NDC: 49693-2001
APPLICATION NUMBER:

Other BACILLUS CEREUS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Sanum Kehlbeck GmbH & Co. KGPleo Lat
SymbiopathicSYMBIO CERE DROPS
USPharmaCoCereus